vs
Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
AVIAT NETWORKS, INC. is the larger business by last-quarter revenue ($111.5M vs $57.3M, roughly 1.9× RHYTHM PHARMACEUTICALS, INC.). AVIAT NETWORKS, INC. runs the higher net margin — 5.1% vs -83.0%, a 88.1% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -5.7%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 0.3%).
Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
AVNW vs RYTM — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $111.5M | $57.3M |
| Net Profit | $5.7M | $-47.5M |
| Gross Margin | 32.4% | 91.6% |
| Operating Margin | 6.5% | -82.2% |
| Net Margin | 5.1% | -83.0% |
| Revenue YoY | -5.7% | 36.9% |
| Net Profit YoY | 27.2% | -9.6% |
| EPS (diluted) | $0.44 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $111.5M | $57.3M | ||
| Q3 25 | $107.3M | $51.3M | ||
| Q2 25 | $115.3M | $48.5M | ||
| Q1 25 | $112.6M | $32.7M | ||
| Q4 24 | $118.2M | $41.8M | ||
| Q3 24 | $88.4M | $33.3M | ||
| Q2 24 | $116.7M | $29.1M | ||
| Q1 24 | $110.8M | $26.0M |
| Q4 25 | $5.7M | $-47.5M | ||
| Q3 25 | $162.0K | $-52.9M | ||
| Q2 25 | $5.2M | $-46.6M | ||
| Q1 25 | $3.5M | $-49.5M | ||
| Q4 24 | $4.5M | $-43.3M | ||
| Q3 24 | $-11.9M | $-43.6M | ||
| Q2 24 | $1.5M | $-32.3M | ||
| Q1 24 | $3.9M | $-141.4M |
| Q4 25 | 32.4% | 91.6% | ||
| Q3 25 | 33.2% | 89.3% | ||
| Q2 25 | 34.2% | 88.6% | ||
| Q1 25 | 34.9% | 88.8% | ||
| Q4 24 | 34.6% | 90.9% | ||
| Q3 24 | 22.4% | 88.5% | ||
| Q2 24 | 35.3% | 89.9% | ||
| Q1 24 | 32.5% | 89.2% |
| Q4 25 | 6.5% | -82.2% | ||
| Q3 25 | 4.8% | -102.6% | ||
| Q2 25 | 7.7% | -93.4% | ||
| Q1 25 | 8.3% | -143.7% | ||
| Q4 24 | 6.7% | -98.6% | ||
| Q3 24 | -17.6% | -132.0% | ||
| Q2 24 | 4.7% | -139.2% | ||
| Q1 24 | 5.1% | -538.7% |
| Q4 25 | 5.1% | -83.0% | ||
| Q3 25 | 0.2% | -103.1% | ||
| Q2 25 | 4.5% | -96.1% | ||
| Q1 25 | 3.1% | -151.4% | ||
| Q4 24 | 3.8% | -103.6% | ||
| Q3 24 | -13.4% | -131.2% | ||
| Q2 24 | 1.3% | -110.9% | ||
| Q1 24 | 3.5% | -544.4% |
| Q4 25 | $0.44 | $-0.73 | ||
| Q3 25 | $0.01 | $-0.82 | ||
| Q2 25 | $0.42 | $-0.75 | ||
| Q1 25 | $0.27 | $-0.81 | ||
| Q4 24 | $0.35 | $-0.71 | ||
| Q3 24 | $-0.94 | $-0.73 | ||
| Q2 24 | $0.11 | $-0.55 | ||
| Q1 24 | $0.30 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.5M | $388.9M |
| Total DebtLower is stronger | $105.4M | — |
| Stockholders' EquityBook value | $271.6M | $139.1M |
| Total Assets | $659.4M | $480.2M |
| Debt / EquityLower = less leverage | 0.39× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $86.5M | $388.9M | ||
| Q3 25 | $64.8M | $416.1M | ||
| Q2 25 | $59.7M | $291.0M | ||
| Q1 25 | $49.4M | $314.5M | ||
| Q4 24 | $52.6M | $320.6M | ||
| Q3 24 | $51.0M | $298.4M | ||
| Q2 24 | $64.6M | $319.1M | ||
| Q1 24 | $59.2M | $201.2M |
| Q4 25 | $105.4M | — | ||
| Q3 25 | $106.5M | — | ||
| Q2 25 | $87.6M | — | ||
| Q1 25 | $73.9M | — | ||
| Q4 24 | $74.9M | — | ||
| Q3 24 | $83.4M | — | ||
| Q2 24 | $48.4M | — | ||
| Q1 24 | $48.9M | — |
| Q4 25 | $271.6M | $139.1M | ||
| Q3 25 | $263.6M | $148.8M | ||
| Q2 25 | $263.2M | $-11.9M | ||
| Q1 25 | $256.1M | $18.9M | ||
| Q4 24 | $249.6M | $21.7M | ||
| Q3 24 | $247.1M | $11.2M | ||
| Q2 24 | $255.9M | $39.3M | ||
| Q1 24 | $256.0M | $61.6M |
| Q4 25 | $659.4M | $480.2M | ||
| Q3 25 | $643.3M | $506.9M | ||
| Q2 25 | $633.3M | $372.7M | ||
| Q1 25 | $628.3M | $386.7M | ||
| Q4 24 | $594.1M | $392.3M | ||
| Q3 24 | $590.9M | $363.6M | ||
| Q2 24 | $535.2M | $381.8M | ||
| Q1 24 | $490.3M | $258.7M |
| Q4 25 | 0.39× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $-25.4M |
| Free Cash FlowOCF − Capex | $22.5M | — |
| FCF MarginFCF / Revenue | 20.2% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | 4.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $-25.4M | ||
| Q3 25 | $-11.7M | $-26.6M | ||
| Q2 25 | $10.5M | $-23.3M | ||
| Q1 25 | $1.6M | $-40.4M | ||
| Q4 24 | $20.8M | $-18.8M | ||
| Q3 24 | $-27.2M | $-25.2M | ||
| Q2 24 | $8.3M | $-29.1M | ||
| Q1 24 | $15.3M | $-40.7M |
| Q4 25 | $22.5M | — | ||
| Q3 25 | $-13.5M | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $18.3M | — | ||
| Q3 24 | $-32.6M | — | ||
| Q2 24 | $7.5M | — | ||
| Q1 24 | $14.8M | — |
| Q4 25 | 20.2% | — | ||
| Q3 25 | -12.6% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | -1.0% | — | ||
| Q4 24 | 15.5% | — | ||
| Q3 24 | -36.8% | — | ||
| Q2 24 | 6.4% | — | ||
| Q1 24 | 13.4% | — |
| Q4 25 | 1.3% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 6.1% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 4.18× | — | ||
| Q3 25 | -72.48× | — | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 4.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.37× | — | ||
| Q1 24 | 3.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
RYTM
Segment breakdown not available.
